Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
myeloma
Apr 20, 2024, 14:04 |
Insight
Myeloma Paper of the Day, April 19th, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X/Twitter: "Myeloma…
Apr 20, 2024, 05:56 |
Insight
Myeloma Paper of the Day suggested by Robert Orlowski, April 18th
Robert Orlowski, Director of the Myeloma Section at MD Anderson Cancer Center, shared on X:…
Apr 18, 2024, 13:58 |
Insight
Ben Derman: Should MRD negativity be accepted as a surrogate endpoint for clinical trials in myeloma
Ben Derman, Assistant Professor at the University of Chicago, shared on X/Twitter: "Should MRD negativity…
Apr 17, 2024, 18:24 |
Insight
Myeloma paper of the Day suggested by Robert Orlowski, April 17th
Robert Orlowski, Director of the Myeloma Section at MD Anderson Cancer Center, shared on X:…
Apr 17, 2024, 10:38 |
Insight
Myeloma Paper of the Day - Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X/Twitter: "Myeloma…
Apr 17, 2024, 10:31 |
Insight
Myeloma Paper of the Day - Robert Orlowski
Robert Orlowski, Director of the Myeloma Section at MD Anderson Cancer Center, shared on X:…
Apr 16, 2024, 20:21 |
Blog
Yelak Biru: Read the Spring Edition of "Myeloma Today," welcoming Vincent Rajkumar as our Board Chair
Yelak Biru, President and Chief Executive Officer at the International Myeloma Foundation, shared a post…
Apr 14, 2024, 12:56 |
Insight
Carl Ola Landgren: Can MRD serve as early endpoint for accelerated approval in myeloma, to facilitate patient’s access to new drugs
Carl Ola Landgren, Professor of Medicine, Chief of Myeloma Division at University of Miami, shared…
Apr 13, 2024, 03:43 |
Blog
FDA ODAC voted 12-0. Historic victory in multiple myeloma
On April 12, 2024, FDA ODAC voted 12-0 in favor of using minimal residual disease…
Apr 9, 2024, 17:56 |
Insight
Myeloma Paper of the Day - Robert Z. Orlowski
Robert Z. Orlowski, Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma…
27
28
29
30
31
All:
577
Posts:
281 - 290
Running for a Cure: The Legacy of Terry Fox's Marathon of Hope
How The Breast Cancer Research Foundation was founded
Can Skin Cancer be Prevented by a $0.50 Soap? Meet TIME’s Kid of the Year and His Invention
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024
Uniting Forces: Leveraging Cancer Research to Revolutionize Tuberculosis Treatment
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube